SGMT
Price
$7.11
Change
-$0.20 (-2.74%)
Updated
Jul 31 closing price
Capitalization
439.06M
16 days until earnings call
Intraday BUY SELL Signals
SYRE
Price
$98.33
Change
-$3.17 (-3.12%)
Updated
Jul 31 closing price
Capitalization
8.54B
3 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SGMT vs SYRE

SGMT vs SYRE Comparison Chart in %
View a ticker or compare two or three
VS
SGMT vs. SYRE commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGMT is a Hold and SYRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (SGMT: $7.11 vs. SYRE: $98.33)
Brand notoriety: SGMT and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SGMT: 30% vs. SYRE: 22%
Market capitalization -- SGMT: $439.06M vs. SYRE: $8.54B
SGMT [@Biotechnology] is valued at $439.06M. SYRE’s [@Biotechnology] market capitalization is $8.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGMT’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • SGMT’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGMT’s TA Score shows that 4 TA indicator(s) are bullish while SYRE’s TA Score has 2 bullish TA indicator(s).

  • SGMT’s TA Score: 4 bullish, 6 bearish.
  • SYRE’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than SYRE.

Price Growth

SGMT (@Biotechnology) experienced а +0.57% price change this week, while SYRE (@Biotechnology) price change was -3.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

SGMT is expected to report earnings on Aug 19, 2026.

SYRE is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($8.54B) has a higher market cap than SGMT($439M). SYRE YTD gains are higher at: 200.153 vs. SGMT (20.101). SGMT has higher annual earnings (EBITDA): -48.74M vs. SYRE (-241.64M). SYRE has more cash in the bank: 741M vs. SGMT (105M). SYRE has less debt than SGMT: SYRE (0) vs SGMT (39K). SGMT (0) and SYRE (0) have equivalent revenues.
SGMTSYRESGMT / SYRE
Capitalization439M8.54B5%
EBITDA-48.74M-241.64M20%
Gain YTD20.101200.15310%
P/E RatioN/A1.72-
Revenue00-
Total Cash105M741M14%
Total Debt39K0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SGMTSYRE
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 8 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 11 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SGMT
Daily Signal:
Gain/Loss:
SYRE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBHC43.190.61
+1.43%
NATIONAL BANK HOLDINGS Corp
ALLT7.610.10
+1.33%
Allot Ltd
BHST2.160.02
+0.93%
Bioharvest Sciences Inc
FDS263.200.17
+0.06%
Factset Research Systems
KRAQU10.10N/A
N/A
Krakacquisition Corp

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with VIR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-2.74%
VIR - SGMT
41%
Loosely correlated
-2.70%
EDIT - SGMT
40%
Loosely correlated
-4.09%
SYRE - SGMT
37%
Loosely correlated
-3.12%
INBX - SGMT
37%
Loosely correlated
-3.16%
GOSS - SGMT
37%
Loosely correlated
-4.94%
More